Page 108 - MemoriaOBN-Eng

RESEARCH GROUPS
ó

é

áó
íó

áí
í

áñ
á
íí
íá
í
íéí
í
é

óó

Investigación y Desarrollo en Obesidad
PROGRAMME:
PROGRAMA:
Grupo 3
y Enfermedades Asociadas
P3. Complications of obesity
Depresin,
and childhood obesity
Transtorno bipolar

Group Members
Lead Researcher

STAFF MEMBERS
Tinahones Madueño, Francisco

Coin Arnguez, Leticia
Garrido Snchez, Lourdes
Contact:
Oliva Olivera, Wilfredo
Phone: (+34) 951 034 016 Picn Csar, Inmaculada Concepcin
E.mail: [email protected]

ASSOCIATED MEMBERS
Barbarroja Puerto, Nuria
Main lines of research
Cardona Daz, Fernando
Clemente Postigo, Mara Mercedes

El Bekay, Raja • Microbiota and related diseases. This line is going to study the intestinal
Fernndez Garca, Diego bacterial microflora profiles in lean and obese patients with and without

Fernndez Garca, Jos Carlo insulin resistance to establish the role of this microflora in the origin of
Garca Almeida, Jos Manuel obesity and insulin resistance. We have also started a subline that analy-

Garca Fuentes, Eduardo zes changes in the microbiota that can cause certain nutrients rich in po-

Gmez Huelgas, Ricardo lyphenols and the relationship of these changes to metabolic diseases.
Lpez Siguero, Juan Pedro
• Development of metabolic syndrome and lipodystrophy in HIV-infected pa-
Macias Gonzlez, Manuel tients. The aim of this line is to study the possible association of oxidati- 13
Mancha Doblas, Isabel 0
ve stress, chronic inflammatory status and antiretroviral therapy with the 2
Moreno Indias, Isabel RT
Murri Pierri, Mora development of metabolic syndrome (MS) and lipodystrophy (LP) in HIV- O
infected patients, by analysis of the most relevant blood biomarkers levels.
EP
Queipo Ortuo, Mara Isabel R
• Obesity and associated diseases. We study the relationship between obe- AL
Roca Rodrguez, Mara del Mar U
Villalobos Martnez, Elena
sity and related metabolic diseases. We tried to elucidate the mecha- NN
A
nisms that protect certain individuals with obesity to develop metabolic /
diseases or to develop these much later. Among the diseases associated N
OB
with obesity, diabetes and postprandial lipemia are two of the areas whe- R
BE
re we are deepening.
CI

108